Zhang, D., Adegunsoye, A., Oldham, J. M., Kozlitina, J., Garcia, N., Poonawalla, M., Strykowski, R., Linderholm, A. L., Ley, B., Ma, S.-F., Noth, I., Strek, M. E., Wolters, P. J., Garcia, C. K., & Newton, C. A. (2023). Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. European Respiratory Journal, 62(5), 2300441. https://doi.org/10.1183/13993003.00441-2023

Kavoosi, S., Picard, M., & Kaufman, B. A. (2024). TFAM mislocalization during spermatogenesis. Trends in Genetics, 40(2), 112–114. https://doi.org/10.1016/j.tig.2023.11.002

Brynte, C., Konstenius, M., Khemiri, L., Bäcker, A., Guterstam, J., Levin, F. R., Jayaram-Lindström, N., & Franck, J. (2023). The Effect of Methylphenidate on Cognition in Patients with Comorbid Attention Deficit/Hyperactivity Disorder and Amphetamine Use Disorder: An Exploratory Single-Blinded within-Subject Study. European Addiction Research, 30(1), 1–13. Portico. https://doi.org/10.1159/000535016

Asai, M., Nishizaki, Y., Nojiri, S., Nakagami, S., Dohmae, S., Suzuki, Y., Chiba, T., Yokoyama, M., & Minamino, T. (2023). The impact of cardiac rehabilitation for older adults with heart failure who underwent invasive cardiac treatment eligible for long‐term care needs certification: A retrospective cohort study. Journal of General and Family Medicine, 25(1), 36–44. Portico. https://doi.org/10.1002/jgf2.663

Livne, O., Malte, C. A., Olfson, M., Wall, M. M., Keyes, K. M., Maynard, C., Gradus, J. L., Saxon, A. J., Martins, S. S., Keyhani, S., McDowell, Y., Fink, D. S., Mannes, Z. L., Gutkind, S., & Hasin, D. S. (2024). Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019. American Journal of Psychiatry, 181(2), 144–152. https://doi.org/10.1176/appi.ajp.20230168

Instrella, R., & Juchem, C. (2023). Uncertainty propagation in absolute metabolite quantification for in vivo MRS of the human brain. Magnetic Resonance in Medicine, 91(4), 1284–1300. Portico. https://doi.org/10.1002/mrm.29903

Api, A. M., Belsito, D., Botelho, D., Bruze, M., Burton, G. A., Cancellieri, M. A., Chon, H., Dagli, M. L., Dekant, W., Deodhar, C., Fryer, A. D., Jones, L., Joshi, K., Kumar, M., Lapczynski, A., Lavelle, M., Lee, I., Liebler, D. C., Moustakas, H., … Tokura, Y. (2024). Update to RIFM fragrance ingredient safety assessment, ethyl phenylacetate, CAS Registry Number 101-97-3. Food and Chemical Toxicology, 183, 114263. https://doi.org/10.1016/j.fct.2023.114263

Tucker, E., Reyes Nieva, H., Schiffer, K., Yin, M. T., Castor, D., Gordon, P., Elhadad, N., & Zucker, J. (2023). Using a Health Information Exchange to Characterize Changes in HIV Viral Load Suppression and Disparities During the COVID-19 Pandemic in New York City. Open Forum Infectious Diseases, 10(12). https://doi.org/10.1093/ofid/ofad584

Yalcinkaya, M., Liu, W., Thomas, L.-A., Olszewska, M., Xiao, T., Abramowicz, S., Papapetrou, E. P., Westerterp, M., Wang, N., Tabas, I., & Tall, A. R. (2023). BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis. Circulation, 148(22), 1764–1777. https://doi.org/10.1161/circulationaha.123.065344

Graham-Perel, A. (2024). Cultural Humility and Diversity in Nursing Academia. Nursing Clinics of North America, 59(1), 11–19. https://doi.org/10.1016/j.cnur.2023.11.003

Fan, W., Chen, Q., Maccarrone, V., Luk, L., Navot, B., & Salvatore, M. (2024). Developing radiology diagnostic tools for pulmonary fibrosis using machine learning methods. Clinical Imaging, 106, 110047. https://doi.org/10.1016/j.clinimag.2023.110047

Ziv, T., Shefner, R., & Sufrin, C. (2023). Editorial. International Journal of Prisoner Health, 19(4), 489–491. https://doi.org/10.1108/ijph-12-2023-120

Kanter, J., Thompson, A. A., Kwiatkowski, J. L., Parikh, S., Mapara, M., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Gupta, A. O., Zhang, L., Sheldon-Waniga, E., Gallagher, M., Gruppioni, K., Chawla, A., Elliot, H., Pierciey, F. J., Walters, M. C., & Tisdale, J. F. (2023). Efficacy, Safety, and Health-Related Quality of Life (HRQOL) in Patients with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up. Blood, 142(Supplement 1), 1051–1051. https://doi.org/10.1182/blood-2023-174229

Yang, J., Huggins, A. A., Sun, D., Baird, C. L., Haswell, C. C., Frijling, J. L., Olff, M., van Zuiden, M., Koch, S. B. J., Nawijn, L., Veltman, D. J., Suarez-Jimenez, B., Zhu, X., Neria, Y., Hudson, A. R., Mueller, S. C., Baker, J. T., Lebois, L. A. M., Kaufman, M. L., … Sotiras, A. (2023). Examining the association between posttraumatic stress disorder and disruptions in cortical networks identified using data-driven methods. Neuropsychopharmacology, 49(3), 609–619. https://doi.org/10.1038/s41386-023-01763-5

Brown, J. R., Eichhorst, B. F., Lamanna, N., O’Brien, S. M., Tam, C. S., Qiu, L., Kaźmierczak, M., Jurczak, W., Zhou, K., Simkovic, M., Mayer, J., Gillespie-Twardy, A. L., Ferrajoli, A., Ganly, P. S., Weinkove, R., Grosicki, S., Mital, A., Robak, T., Osterborg, A., … Shadman, M. (2023). Extended Follow-up of ALPINE Randomized Phase 3 Study Confirms Sustained Superior Progression-Free Survival of Zanubrutinib Versus Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL). Blood, 142(Supplement 1), 202–202. https://doi.org/10.1182/blood-2023-174289

Wang, E. S., Jonas, B. A., Watts, J. M., Jurcic, J., Ferrell, P. B., Dinner, S. N., Yang, J., Seiter, K., Mims, A., Donnellan, W. B., Blum, W., & Cortes, J. (2023). Factors Impacting Response to Olutasidenib in Patients with mIDH1 Acute Myeloid Leukemia. Blood, 142(Supplement 1), 6047–6047. https://doi.org/10.1182/blood-2023-187584

Nyongesa, P., Ekhaguere, O. A., Marete, I., Tenge, C., Kemoi, M., Bann, C. M., Bucher, S. L., Patel, A. B., Hibberd, P. L., Naqvi, F., Saleem, S., Goldenberg, R. L., Goudar, S. S., Derman, R. J., Krebs, N. F., Garces, A., Chomba, E., Carlo, W. A., Mwenechanya, M., … Esamai, F. (2023). Maternal age extremes and adverse pregnancy outcomes in low-resourced settings. Frontiers in Global Women’s Health, 4. https://doi.org/10.3389/fgwh.2023.1201037

Gui, G., Dillon, L. W., Ravindra, N., Hegde, P. S., Andrew, G., Mukherjee, D., Wong, Z., Auletta, J. J., El Chaer, F., Chen, E. C., Chen, Y.-B., Corner, A., Devine, S. M., Iyer, S. G., Jimenez Jimenez, A. M., de Lima, M., Litzow, M. R., Kebriaei, P., Saber, W., … Hourigan, C. S. (2023). Measurable Residual IDH2 before Allogeneic Transplant for Acute Myeloid Leukemia. Blood, 142(Supplement 1), 424–424. https://doi.org/10.1182/blood-2023-186822

Woerner, J., Chadwick, S. B., Antebi-Gruszka, N., Siegel, K., & Schrimshaw, E. W. (2023). Negative Sexual Experiences Among Gay, Bisexual, and Other Men Who Have Sex with Men Using GPS-Enabled Hook-Up Apps and Websites. The Journal of Sex Research, 1–16. https://doi.org/10.1080/00224499.2023.2269930

Cortes, J., Jurcic, J., Baer, M. R., Blum, W., Ferrell, P. B., Jonas, B. A., Lee, S., Mims, A., Patel, S. A., Schiller, G. J., Yang, J., & Watts, J. M. (2023). Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax. Blood, 142(Supplement 1), 2888–2888. https://doi.org/10.1182/blood-2023-187861

Mariani, J. J., Basaraba, C., Pavlicova, M., Alschuler, D. M., Brooks, D. J., Mahony, A. L., Brezing, C., Naqvi, N. H., & Levin, F. R. (2023). Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder. The American Journal of Drug and Alcohol Abuse, 49(5), 618–629. https://doi.org/10.1080/00952990.2023.2241981

Snyder, D. J., Zilinyi, R. S., Cohen, D. J., Parikh, S. A., & Sethi, S. S. (2023). Patient‐Reported Outcomes in Venous Thromboembolism: A Systematic Review of the Literature, Current Challenges, and Ways Forward. Journal of the American Heart Association, 12(23). https://doi.org/10.1161/jaha.123.032146

Daver, N., Zeidner, J. F., Yuda, J., Watts, J. M., Levis, M. J., Fukushima, K., Ikezoe, T., Ogawa, Y., Brandwein, J., Wang, E. S., Miyazaki, Y., Pardee, T., Hosono, N., Shima, T., Yokoyama, H., Asada, N., Jurcic, J., Cai, H., Watanabe, A., … Erba, H. P. (2023). Phase 1/2 First-in-Human Study of the Menin-MLL Inhibitor DSP-5336 in Patients with Relapsed or Refractory Acute Leukemia. Blood, 142(Supplement 1), 2911–2911. https://doi.org/10.1182/blood-2023-179252

Tudor, T., Spinazzi, E. F., Alexander, J. E., Mandigo, G. K., Lavine, S. D., Grinband, J., & Connolly, E. S. (2023). Progressive microvascular failure in acute ischemic stroke: A systematic review, meta-analysis, and time-course analysis. Journal of Cerebral Blood Flow & Metabolism, 44(2), 192–208. https://doi.org/10.1177/0271678x231216766

Nelson, L., Ing, S. W., Rubin, M. R., Ma, J., Martin, S., Sen, R., & Ayodele, O. (2023). Psychometric Analysis of the Patient-Reported Hypoparathyroidism Symptom Diary Symptom Subscale Using Data from Two Clinical Trials. Patient Related Outcome Measures, Volume 14, 355–367. https://doi.org/10.2147/prom.s414794

Chakraborty, R., Bhutani, D., Mapara, M., Reshef, R., Maurer, M. S., Radhakrishnan, J., & Lentzsch, S. (2023). Reduced Early Mortality with Daratumumab-Based Frontline Therapy in Systemic AL Amyloidosis- Experience from the Columbia Amyloidosis Multidisciplinary Program. Blood, 142(Supplement 1), 4780–4780. https://doi.org/10.1182/blood-2023-187214

Membreno, R., Thomas, K. R., Calcetas, A. T., Edwards, L., Bordyug, M., Showell, M., Stanfill, M., Brenner, E. K., Walker, K. S., Rotblatt, L. J., Brickman, A. M., Edmonds, E. C., & Bangen, K. J. (2023). Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia. Alzheimer Disease & Associated Disorders, 37(4), 303–309. https://doi.org/10.1097/wad.0000000000000585

Levine, S. R., Myers, M. G., Barunas, R., Chang, D. S., Dutta, S., Maddess, T., Liebmann, J. M., Sherman, S., Eydelman, M., Sun, J. K., Chambers, W., Wickström, K., Luhmann, U. F. O., Pallinat, M., Glassman, A., Aiello, L. P., Markel, D. S., & Gardner, T. W. (2023). Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop. Translational Vision Science & Technology, 12(11), 33. https://doi.org/10.1167/tvst.12.11.33

Diefenbach, C. S., Jegede, O., Ansell, S. M., Steidl, C., Natkunam, Y., Scott, D. W., Mehta-Shah, N., Amengual, J. E., Forlenza, C. J., Cole, P. D., Bartlett, N. L., David, K. A., Advani, R. H., Ambinder, R. F., Thomas, S., Ibrahimi, S., & Kahl, B. S. (2023). Results from an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Research Group (E4412). Blood, 142(Supplement 1), 607–607. https://doi.org/10.1182/blood-2023-184531

Api, A. M., Belsito, D., Botelho, D., Bruze, M., Burton, G. A., Cancellieri, M. A., Chon, H., Dagli, M. L., Date, M., Dekant, W., Deodhar, C., Fryer, A. D., Jones, L., Joshi, K., Kumar, M., Lapczynski, A., Lavelle, M., Lee, I., Liebler, D. C., … Tokura, Y. (2024). RIFM fragrance ingredient safety assessment, 4-hydroxy-3-pentenoic acid lactone, CAS Registry number 591-12-8. Food and Chemical Toxicology, 183, 114228. https://doi.org/10.1016/j.fct.2023.114228

Api, A. M., Belsito, D., Botelho, D., Bruze, M., Burton, G. A., Cancellieri, M. A., Chon, H., Dagli, M. L., Date, M., Dekant, W., Deodhar, C., Fryer, A. D., Jones, L., Joshi, K., Kumar, M., Lapczynski, A., Lavelle, M., Lee, I., Liebler, D. C., … Tokura, Y. (2023). RIFM fragrance ingredient safety assessment, allyl cyclohexaneacetate, CAS Registry Number 4728-82-9. Food and Chemical Toxicology, 182, 114254. https://doi.org/10.1016/j.fct.2023.114254

Api, A. M., Belsito, D., Botelho, D., Bruze, M., Burton, G. A., Cancellieri, M. A., Chon, H., Dagli, M. L., Dekant, W., Deodhar, C., Fryer, A. D., Jones, L., Joshi, K., Kumar, M., Lapczynski, A., Lavelle, M., Lee, I., Liebler, D. C., Moustakas, H., … Tokura, Y. (2024). RIFM fragrance ingredient safety assessment, decahydro-β-naphthyl formate, CAS Registry Number 10519-12-7. Food and Chemical Toxicology, 183, 114249. https://doi.org/10.1016/j.fct.2023.114249

Shadman, M., Tedeschi, A., Mohseninejad, L., Yang, K., Lamanna, N., Xu, S., Cohen, A. C., Challagulla, S., Xue, M., Williams, R., O’Brien, S. M., Brown, J. R., & Tam, C. S. (2023). Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison. Blood, 142(Supplement 1), 4655–4655. https://doi.org/10.1182/blood-2023-179222

Mohan, M., Shah, N., Luan, D., Monge, J., Forsberg, M., Bhatlapenumarthi, V., Balev, M., Patwari, A., Cheruvalath, H., Bhutani, D., Thanendrarajan, S., Dhakal, B., Zangari, M., Al Hadidi, S., Cooper, D. L., Lentzsch, S., van Rhee, F., D’Souza, A., Szabo, A., … Chakraborty, R. (2023). Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study. Blood, 142(Supplement 1), 545–545. https://doi.org/10.1182/blood-2023-174875

Liman, T. G., Siegerink, B., Piper, S., Catar, R., Moll, G., Riemekasten, G., Heidecke, H., Heuschmann, P. U., Elkind, M. S. V., Dragun, D., & Endres, M. (2023). Vasoregulatory Autoantibodies and Clinical Outcome After Ischemic Stroke—PROSCIS‐B. Journal of the American Heart Association, 12(23). https://doi.org/10.1161/jaha.123.032441

Motter, J. D., Hussain, S., Brown, D. M., Florman, S., Rana, M. M., Friedman-Moraco, R., Gilbert, A. J., Stock, P., Mehta, S., Mehta, S. A., Stosor, V., Elias, N., Pereira, M. R., Haidar, G., Malinis, M., Morris, M. I., Hand, J., Aslam, S., … Schaenman, J. M. (2023). Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act. Transplantation, 108(3), 759–767. https://doi.org/10.1097/tp.0000000000004857

Theodore, D., Neradilek, M., Gillespie, K., Edupuganti, S., Hinojosa, J. C., Lama, J. R., De La Grecca, R., Davis, A., Mangini, D. J., Andrew, P., Marovich, M., Zwerski, S., Castor, D., Roxby, A. C., Cohen, M., Corey, L., Huang, Y., Karuna, S., & Sobieszczyk, M. E. (2023). 1558. Associations between gender identity and solicited adverse events after passive infusion of VRC01 or placebo in HVTN 704/HPTN 085. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.1393

Rolfes, M. A., Talbot, H. K., Grace Morrissey, K., Stockwell, M., Maldonado, Y. A., McLean, H., Lutrick, K., Bowman, N. M., Rao, S., Salvatore, P. P., Izurieta, H., Schmitz, J., Zhu, Y., Hart, K. W., Battan-Wraith, S., Merrill, L. S., McLaren, S. H., Sano, E., Sarnquist, C., … Grijalva, C. G. (2023). 2080. Reduced risk of SARS-CoV-2 infection among household contacts with hybrid immunity from recent COVID-19 vaccination and SARS-CoV-2 infection. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.150

Goodman, S. H., Mellis, A., Grijalva, C. G., Keipp Talbot, H., Stockwell, M., McLaren, S. H., Sano, E., Rao, S., Asturias, E. J., McLean, H., Belongia, E., Govindaranjan, P., Sarnquist, C., Maldonado, Y. A., Ellingson, K., Lutrick, K., Bowman, N. M., Smith-Jeffcoat, S. E., Rolfes, M. A., … Lin, J. T. (2023). 2293. Examining social vulnerability and its effect on COVID-19 transmission in households. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.1915

Mellis, A., Smith-Jeffcoat, S. E., Petrie, J., Keipp Talbot, H., Morrissey, K. G., Stockwell, M., Maldonado, Y. A., Bowman, N. M., Lutrick, K., Rao, S., Salvatore, P. P., Biddle, J. E., Olivo, V., Battan-Wraith, S., Merrill, L. S., McLaren, S. H., Sano, E., Diaz, A., Sarnquist, C., … Grijalva, C. G. (2023). 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.1924

Saiman, L., Walsh, E. E., Branche, A. R., Barrett, A., Alba, L. R., Gollerkeri, S., Schillinger, J. A., PHILLIPS, M. A. T. T. H. E. W. R., & Finelli, L. (2023). 2313. Population-based Incidence of SARS-CoV-2-associated Hospitalizations across the Age Spectrum in New York City, 2020-2021. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.1935

Holodniy, M., Pei, Y., Stack, G., Wade, C. L., Agrawal, Y., Barasch, N., Baddoura, F., Carmen Frias-Kletecka, M., Stacey Klutts, J., & Wang-rodriguez, J. (2023). 2353. SARS-CoV-2 Variants among US Veterans after COVID-19 Bivalent Vaccine Administration. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.1974

DeLaurentis, C., Hokunson, T. W., Nelson, B., Annavajhala, M. K., Uhlemann, A.-C., & Gomez-Simmonds, A. (2023). 2576. Piperacillin-Tazobactam or Cefepime for Treatment of Third Generation Cephalosporin Resistant Pneumonia in Intensive Care Unit Patients. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.2192

Gunaratne, S., Huang, S., McLean, J., DeLaurentis, C., & Zucker, J. (2023). 2666. Rates of STI Testing and Diagnoses among Patients with Mpox in New York City, 2022. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.2277

Zheng, T., Mehta, M., Stilwell, A., & Demenagas, N. (2023). 2849. Doxycycline for the Treatment of Urinary Tract Infections. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.2459

Floris-Moore, M., Stockwell, M., Grijalva, C. G., Keipp Talbot, H., Mellis, A., Smith-Jeffcoat, S. E., Rolfes, M. A., Saydah, S., Biddle, J. E., Lin, J. T., Schmitz, J., Chappell, J., Hart, K. W., McLaren, S. H., Sano, E., Saiman, L., Maldonado, Y. A., Ellingson, K., Lutrick, K., … Bowman, N. M. (2023). 400. Predictors of Post-COVID Conditions after SARS-CoV-2 Infection in Adults Enrolled in a Multistate Household Transmission Study. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.470

Huang, S., Zucker, J., Castor, D., Carnevale, C., LaSota, E., Klein, J., Kim, T. Y., Quigee, D., Theodore, D., Gordon, P., Cohall, A., Meyers, K., & Sobieszczyk, M. E. (2023). 476. Increased Depression and Anxiety Associated with COVID-19 among Recipients of HIV Healthcare Services at Sexual Health Clinic in NYC. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.546

Singh, H. K., Ross, B., Quinn, M., Calfee, D. P., Simon, M., Torres, H. M., Acker, K. P., Horowitz, H., Wang, T. Z., Gunawardhana, N., Goldberg, R. H., Segal-Maurer, S., Prasad, N., Johnson, C. L., Kuang, D., Gouveia, A. L., Yoko Furuya, E., Westervelt, K., & Saiman, L. (2023). 745. Title: Epidemiology of Hospital-onset Bacteremia (HOB) caused by Methicillin-resistant Staphylococcus aureus (MRSA) in a Multi-hospital Health System. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.806

Mellis, A., Biddle, J. E., Antoon, J. W., McLaren, S. H., Belongia, E., Maldonado, Y. A., Bowman, N. M., Ellingson, K., Rao, S., Johnson, S., Stockwell, M., Sano, E., Silverio, R. A., Bullock, A., Yang, A., Haehnel, Q., McLean, H., Petrie, J., Sarnquist, C., … Rolfes, M. A. (2023). 925. Oseltamivir usage in community settings: data from a household transmission study. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.970

Smith-Jeffcoat, S. E., Biddle, J. E., Talbot, H. K., Olivo, V., Sano, E., Goodman, S. H., Petrie, J., Ledezma, K. I., Bullock, A., Rao, S., Mellis, A., Johnson, S., Kirking, H. L., Rolfes, M. A., Zhu, Y., Schmitz, J., Hart, K. W., Battan-Wraith, S., Merrill, L. S., … Salvatore, P. P. (2023). 930. COVID-19 symptom and viral load rebound among individuals reporting nirmatrelvir/ritonavir use compared to propensity score matched individuals not taking COVID-19 treatment. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.975